Frank V. Fossella

Statistics

Publications

137

Citations

18.4K

H-Index

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

Eli Lilly (United States)

Frank V. Fossella is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and non-small cell lung cancer therapy.

Publications per year

1991–2025

137

Publications

137

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella et al. · Journal of Clinical Oncology · 2004 · 2.4K citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

Frank V. Fossella, Russell F. DeVore, Ronald N. Kerr et al. · Journal of Clinical Oncology · 2000 · 1.4K citations

Medicine, Oncology, Pharmacology +10

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

Jack A. Roth, Frank V. Fossella, R. Komaki et al. · JNCI Journal of the National Cancer Institute · 1994 · 1.1K citations

Medicine, Oncology, Surgery +13

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel et al. · Journal of Clinical Oncology · 2003 · 943 citations

Medicine, Oncology, Pharmacology +15

The BATTLE Trial: Personalizing Therapy for Lung Cancer

Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba et al. · Cancer Discovery · 2011 · 893 citations

Medicine, Oncology, Pharmacology +17

1–5 of 137